Lecigon, Gel zur intestinalen Anwendung

7680683600013 CH-68360 Gel zur intestinalen Anwendung

Associated product:

LECIGON gel 7 x 47 ml
Lecigon, Gel zur intestinalen Anwendung
Lecigon, Gel zur intestinalen Anwendung
Lecigon, Gel zur intestinalen Anwendung
1 / 3
google

Article details

Package size
7 x 47
Selling units
7
Measure
ml
Galenic form
Gel zur intestinalen Anwendung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
11/09/2024
Patient information leaflet
Français
11/09/2024
Patient information leaflet
Italien
11/09/2024
Summary of Product Characteristics
Allemand
11/09/2024
Summary of Product Characteristics
Français
11/09/2024
Summary of Product Characteristics
Italien
11/09/2024

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
5.0 MG Substance WIZUS
(N/A)
4.6 MG Substance Wirkstoff (Principe actif)
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI

Reimbursement information

Public price
CHF 423.60
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2025

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
68360
Drug name
Lecigon, Gel zur intestinalen Anwendung
Galenic form
GELIA
ATC Code
N04BA03
Authorization status
Z
Dispensing category
B
First authorization
02/02/2022
Authorization expiration date
01/02/2027
IT Number
01.08.0.
Domain
Human medicine
Field of application
Behandlung der fortgeschrittenen Parkinson-Krankheit

Package details

Description (FR)
LECIGON gel 7 x 47 ml
Description (DE)
LECIGON Gel 7 x 47 ml
Market launch
02/02/2022
Narcotic (BTM)
No